Evaluation of capillary chromatographic supports for immobilized human purine nucleoside phosphorylase in frontal affinity chromatography studies.

[1]  S. Fugmann,et al.  Synthesis and characterization of a SIRT6 open tubular column: predicting deacetylation activity using frontal chromatography. , 2013, Analytical biochemistry.

[2]  Q. Cass,et al.  Immobilized purine nucleoside phosphorylase from Schistosoma mansoni for specific inhibition studies , 2013, Analytical and Bioanalytical Chemistry.

[3]  Amos J. Simon,et al.  Purine nucleoside phosphorylase deficiency presenting as severe combined immune deficiency , 2013, Immunologic research.

[4]  G. Massolini,et al.  New monolithic chromatographic supports for macromolecules immobilization: challenges and opportunities. , 2012, Journal of pharmaceutical and biomedical analysis.

[5]  L. A. Basso,et al.  Capillary bioreactors based on human purine nucleoside phosphorylase: a new approach for ligands identification and characterization. , 2012, Journal of Chromatography A.

[6]  G. Massolini,et al.  Immobilized trypsin on epoxy organic monoliths with modulated hydrophilicity: novel bioreactors useful for protein analysis by liquid chromatography coupled to tandem mass spectrometry. , 2011, Journal of chromatography. A.

[7]  G. Massolini,et al.  Frontal affinity chromatography in characterizing immobilized receptors. , 2011, Journal of pharmaceutical and biomedical analysis.

[8]  Z. Jia,et al.  Rapid, convenient method for screening imidazole-containing compounds for heme oxygenase inhibition. , 2011, Journal of pharmacological and toxicological methods.

[9]  Marcelo Santos Castilho,et al.  Discovery of New Inhibitors of Schistosoma mansoni PNP by Pharmacophore-Based Virtual Screening , 2010, J. Chem. Inf. Model..

[10]  G. Massolini,et al.  Target‐Based Drug Discovery: the Emerging Success of Frontal Affinity Chromatography Coupled to Mass Spectrometry , 2009, ChemMedChem.

[11]  G. Massolini,et al.  Development of an immobilized GPR17 receptor stationary phase for binding determination using frontal affinity chromatography coupled to mass spectrometry. , 2009, Analytical biochemistry.

[12]  J. Brennan,et al.  An ESI‐MS/MS Method for Screening of Small‐Molecule Mixtures against Glycogen Synthase Kinase‐3β (GSK‐3β) , 2008, Chembiochem : a European journal of chemical biology.

[13]  G. Oliva,et al.  The development of an immobilized enzyme reactor containing glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma cruzi: the effect of species' specific differences on the immobilization. , 2008, The Analyst.

[14]  R. Furman,et al.  Purine nucleoside phosphorylase inhibition as a novel therapeutic approach for B-cell lymphoid malignancies. , 2007, Seminars in oncology.

[15]  M. Botta,et al.  Simplified analogues of immucillin-G retain potent human purine nucleoside phosphorylase inhibitory activity. , 2006, Journal of medicinal chemistry.

[16]  J. Brennan,et al.  Immobilized enzyme reactor chromatography: optimization of protein retention and enzyme activity in monolithic silica stationary phases. , 2006, Analytica chimica acta.

[17]  J. Brennan,et al.  Inhibitor screening using immobilized enzyme reactor chromatography/mass spectrometry. , 2005, Analytical chemistry.

[18]  William Ng,et al.  Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 2. Identification of small-molecule inhibitors via coupling with virtual screening. , 2005, Journal of medicinal chemistry.

[19]  I. Wainer,et al.  G-Protein-Coupled Receptor Chromatographic Stationary Phases. 2. Ligand-Induced Conformational Mobility in an Immobilized β2-Adrenergic Receptor , 2004 .

[20]  Jin-Rui Dai,et al.  Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 1. Comparison with conventional ELISA. , 2004, Journal of medicinal chemistry.

[21]  G. Massolini,et al.  Evaluation of a monolithic epoxy silica support for penicillin G acylase immobilization. , 2004, Journal of chromatography. A.

[22]  I. Wainer,et al.  Syntheses of immobilized G protein-coupled receptor chromatographic stationary phases: characterization of immobilized mu and kappa opioid receptors. , 2003, Analytical chemistry.

[23]  David C Schriemer,et al.  Frontal affinity chromatography-mass spectrometry assay technology for multiple stages of drug discovery: applications of a chromatographic biosensor. , 2003, Analytical biochemistry.

[24]  L. A. Basso,et al.  Cloning, overexpression, and purification of functional human purine nucleoside phosphorylase. , 2003, Protein expression and purification.

[25]  K. Nakanishi,et al.  Monolithic HPLC Silica Columns , 2002 .

[26]  D Shugar,et al.  Purine nucleoside phosphorylases: properties, functions, and clinical aspects. , 2000, Pharmacology & therapeutics.

[27]  A. Lundqvist,et al.  Biomembrane affinity chromatographic analysis of nitrobenzylthioinosine binding to the reconstituted human red cell nucleoside transporter , 1998, Journal of molecular recognition : JMR.

[28]  A. Lundqvist,et al.  Biomembrane affinity chromatographic analysis of inhibitor binding to the human red cell nucleoside transporter in immobilized cells, vesicles and proteoliposomes. , 1998, Biochimica et biophysica acta.

[29]  E. Brekkan,et al.  Immobilized membrane vesicle or proteoliposome affinity chromatography. Frontal analysis of interactions of cytochalasin B and D-glucose with the human red cell glucose transporter. , 1996, Biochemistry.